Kiel symposium addressed ethical, economic and epistemological questions for precision medicine in chronic inflammatory diseases.
In a clinical phase 2 study, a research team involving Kiel has demonstrated the effectiveness of an IL-23 blocking treatment against psoriasis, which…
A special kind of annual review: five young researchers from the PMI cluster presented their high-ranking published work from 2023 to the other…
Comparative genome study of the CRC 1182 using humans and great apes provides new insights into the development and adaptation of the gut microbiome…
Professor Konrad Aden receives funding from the Joachim Herz Foundation's Innovation Academy to find a metabolic biomarker for chronic inflammation.
German Research Foundation continues to fund the CRC 1182 until 2027
Five members of the Cluster of Excellence "Precision Medicine in Chronic Inflammation" are among the most frequently cited researchers worldwide in…
Researchers from an international consortium led by the Research Center Borstel, Leibniz Lung Center report on the worrying spread of…
The Cluster of Excellence "Precision Medicine in Chronic Inflammation" organized a symposium on gender-sensitive medicine and women in science
The Cluster of Excellence PMI has awarded three of its most exceptional female researchers in Lübeck, Borstel and Kiel the highly endowed Dorothea…
fbuhse@uv.uni-kiel.de +49 (0)431/880 4682
This website uses cookies. By continuing to visit this website, you agree to the use of cookies.